Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients.

MLA

Drymel, Bernadeta, et al. “Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients.” International Journal of Molecular Sciences, vol. 25, no. 23, Dec. 2024. EBSCOhost, https://doi.org/10.3390/ijms252312982.

APA

Drymel, B., Tomela, K., Galus, Ł., Olejnik-Schmidt, A., Mackiewicz, J., Kaczmarek, M., Mackiewicz, A., & Schmidt, M. (2024). Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients. International Journal of Molecular Sciences, 25(23). https://doi.org/10.3390/ijms252312982

Chicago

Drymel, Bernadeta, Katarzyna Tomela, Łukasz Galus, Agnieszka Olejnik-Schmidt, Jacek Mackiewicz, Mariusz Kaczmarek, Andrzej Mackiewicz, and Marcin Schmidt. 2024. “Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients.” International Journal of Molecular Sciences 25 (23). doi:10.3390/ijms252312982.